These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 15503268

  • 1. First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice.
    Stenhouse EJ, Crossley JA, Aitken DA, Brogan K, Cameron AD, Connor JM.
    Prenat Diagn; 2004 Oct; 24(10):774-80. PubMed ID: 15503268
    [Abstract] [Full Text] [Related]

  • 2. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D, Langlois S, Douglas Wilson R, SOGC GENETICS COMMITTEE, CCMG PRENATAL DIAGNOSIS COMMITTEE.
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [Abstract] [Full Text] [Related]

  • 3. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation.
    Wright D, Spencer K, Kagan K K, Tørring N, Petersen OB, Christou A, Kallikas J, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2010 Oct; 36(4):404-11. PubMed ID: 20658511
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S, Spencer K, Avgidou K, Faiola S, Nicolaides KH.
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [Abstract] [Full Text] [Related]

  • 8. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K, Nicolaides KH.
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [Abstract] [Full Text] [Related]

  • 9. First-trimester contingent screening for Down syndrome can reduce the number of nuchal translucency measurements required.
    Vadiveloo T, Crossley JA, Aitken DA.
    Prenat Diagn; 2009 Jan; 29(1):79-82. PubMed ID: 19097036
    [Abstract] [Full Text] [Related]

  • 10. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS, Huang YY, Hwa KY, Cheng CC, Lee FK.
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [Abstract] [Full Text] [Related]

  • 11. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [Abstract] [Full Text] [Related]

  • 12. Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study.
    Crossley JA, Aitken DA, Cameron AD, McBride E, Connor JM.
    BJOG; 2002 Jun; 109(6):667-76. PubMed ID: 12118646
    [Abstract] [Full Text] [Related]

  • 13. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X, Chang Y, Cui HY, Ren CC, Yu BY.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [Abstract] [Full Text] [Related]

  • 14. First trimester risk assessment for trisomy 21 in twin pregnancies combining nuchal translucency and first trimester biochemical markers.
    Prats P, Rodríguez I, Comas C, Puerto B.
    Prenat Diagn; 2012 Oct; 32(10):927-32. PubMed ID: 22752980
    [Abstract] [Full Text] [Related]

  • 15. Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.
    Soergel P, Pruggmayer M, Schwerdtfeger R, Muhlhaus K, Scharf A.
    Fetal Diagn Ther; 2006 Oct; 21(3):264-8. PubMed ID: 16601335
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of human chorionic gonadotropin (beta hCG) levels and sonographic assesement of fetal nuchal translucency (NT) in singleton pregnancies between 11 and 14 weeks of gestation--Polish multi-centre research].
    Borowski D, Czuba B, Cnota W, Hincz P, Czekierdowski A, Gajewska J, Jaczyńska R, Ceran A, Włoch A, Wyrwas D, Wiełgoś M, Szymusik I, Szaflik K, Sodowski K.
    Ginekol Pol; 2007 May; 78(5):384-7. PubMed ID: 17867331
    [Abstract] [Full Text] [Related]

  • 17. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O.
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [Abstract] [Full Text] [Related]

  • 18. Comparison of first-trimester contingent screening strategies for Down syndrome.
    Sahota DS, Leung TY, Chan LW, Law LW, Fung TY, Chen M, Lau TK.
    Ultrasound Obstet Gynecol; 2010 Mar; 35(3):286-91. PubMed ID: 20052660
    [Abstract] [Full Text] [Related]

  • 19. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.
    Cicero S, Bindra R, Rembouskos G, Spencer K, Nicolaides KH.
    Prenat Diagn; 2003 Apr; 23(4):306-10. PubMed ID: 12673635
    [Abstract] [Full Text] [Related]

  • 20. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
    Laigaard J, Spencer K, Christiansen M, Cowans NJ, Larsen SO, Pedersen BN, Wewer UM.
    Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.